CD7 CAR T-Cell Therapy and Allogeneic HSCT. Reply

N Engl J Med. 2024 Jul 4;391(1):93. doi: 10.1056/NEJMc2406366.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Leukemia / therapy
  • Lymphoma / therapy
  • Receptors, Antigen, T-Cell / therapeutic use
  • Receptors, Chimeric Antigen / immunology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / transplantation
  • Transplantation, Homologous

Substances

  • Receptors, Antigen, T-Cell
  • Receptors, Chimeric Antigen